Lorcaserin Extended-Release Tablets and Hematological abnormalities
Result of checking the interaction of drug Lorcaserin Extended-Release Tablets and disease Hematological abnormalities for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Hematological changes, including decreases in hemoglobin and hematocrit counts, have been reported with the use of lorcaserin. Caution should be exercised when treating patients who have ongoing or a history of significant hematologic abnormalities. It is recommended to consider periodic monitoring of complete blood count during treatment.
Generic Name: lorcaserin
Brand Name: Belviq, Belviq XR
Synonyms: Lorcaserin